{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:05:34Z","timestamp":1787241934830,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medical Research Council","award":["MR\/R006504\/1"],"award-info":[{"award-number":["MR\/R006504\/1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The diagnostic precision of Parkinsonian disorders is not accurate enough. Even in expert clinics, up to one in five diagnoses are incorrect. Gold standard diagnosis is post-mortem confirmation of the underlying proteinopathy; however, many clinicopathological studies focus on either a single disease or frame analyses in one temporal direction that may underestimate the true extent of mis- and missed diagnoses. We identified 125 published clinicopathological studies since 1992, extracted phenotype information for ~9200 post-mortem cases, curated the data in a standardised machine-readable format and used this to develop a probabilistic model to quantify diagnostic likelihood based on clinical observations. We found diagnostic accuracy was highest for multiple system atrophy (MSA, 92.8%) and lowest for dementia with Lewy bodies (DLB, 82.1%). MSA and progressive supranuclear palsy were most frequently mis-labelled as Parkinson\u2019s disease (PD) in life (7.2% and 8.3% of cases), whereas the most common PD misdiagnosis was Alzheimer\u2019s (~7% cases). We calculated likelihood ratios for a large range of clinical phenotypes and demonstrated how these can be used to help refine and improve diagnostic accuracy. This work delivers a harmonised, open-source dataset representing over 30 years of published results and represents a key foundation for flexible predictive models that leverage different sources of information to better discriminate Parkinsonian disorders during the early and prodromal phases of the illness.<\/jats:p>","DOI":"10.1038\/s41531-025-01157-y","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T11:26:52Z","timestamp":1762774012000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Refining the diagnostic accuracy of Parkinsonian disorders using metaphenomic annotation of the clinicopathological literature"],"prefix":"10.1038","volume":"11","author":[{"given":"Quin","family":"Massey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonidas","family":"Nihoyannopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Zeidman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Warner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailash","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"1157_CR1","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1002\/mds.26431","volume":"30","author":"D Berg","year":"2015","unstructured":"Berg, D. et al. MDS research criteria for prodromal Parkinson\u2019s disease. Mov. Disord. 30, 1600\u20131611 (2015).","journal-title":"Mov. Disord."},{"key":"1157_CR2","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3233\/JPD-140515","volume":"5","author":"A Hassan","year":"2015","unstructured":"Hassan, A. et al. The profile of long-term Parkinson\u2019s disease survivors with 20 years of disease duration and beyond. J. Parkinsons Dis. 5, 313\u2013319 (2015).","journal-title":"J. Parkinsons Dis."},{"key":"1157_CR3","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3389\/fneur.2018.00156","volume":"9","author":"L Marsili","year":"2018","unstructured":"Marsili, L., Rizzo, G. & Colosimo, C. Diagnostic criteria for Parkinson\u2019s disease: from James Parkinson to the concept of prodromal disease. Front. Neurol. 9, 156 (2018).","journal-title":"Front. Neurol."},{"key":"1157_CR4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41531-024-00712-3","volume":"10","author":"T H\u00e4hnel","year":"2024","unstructured":"H\u00e4hnel, T. et al. Progression subtypes in Parkinson\u2019s disease identified by a data-driven multi cohort analysis. npj Parkinsons Dis. 10, 95 (2024).","journal-title":"npj Parkinsons Dis."},{"key":"1157_CR5","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1001\/jamaneurol.2018.4377","volume":"76","author":"E de Pablo-Fern\u00e1ndez","year":"2019","unstructured":"de Pablo-Fern\u00e1ndez, E., Lees, A. J., Holton, J. L. & Warner, T. T. Prognosis and neuropathologic correlation of clinical subtypes of Parkinson disease. JAMA Neurol. 76, 470\u2013479 (2019).","journal-title":"JAMA Neurol."},{"key":"1157_CR6","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1136\/jnnp.73.5.529","volume":"73","author":"A Schrag","year":"2002","unstructured":"Schrag, A., Ben-Shlomo, Y. & Quinn, N. How valid is the clinical diagnosis of Parkinson\u2019s disease in the community?. J. Neurol. Neurosurg. Psychiatry 73, 529\u2013534 (2002).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1157_CR7","first-page":"136","volume":"2","author":"W Johansen","year":"1909","unstructured":"Johansen, W. Elemente der exakten Erblichkeitslehre. Z. Vererb. 2, 136\u2013137 (1909).","journal-title":"Z. Vererb."},{"key":"1157_CR8","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1093\/bib\/bbx035","volume":"19","author":"GV Gkoutos","year":"2018","unstructured":"Gkoutos, G. V., Schofield, P. N. & Hoehndorf, R. The anatomy of phenotype ontologies: principles, properties and applications. Brief. Bioinform. 19, 1008\u20131021 (2018).","journal-title":"Brief. Bioinform."},{"key":"1157_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12976-015-0017-y","volume":"12","author":"E Younesi","year":"2015","unstructured":"Younesi, E. et al. PDON: Parkinson\u2019s disease ontology for representation and modeling of the Parkinson\u2019s disease knowledge domain. Theor. Biol. Med. Model. 12, 1\u201317 (2015).","journal-title":"Theor. Biol. Med. Model."},{"key":"1157_CR10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes, A. J., Daniel, S. E., Kilford, L. & Lees, A. J. Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 55, 181\u2013184 (1992).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1157_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.557","volume":"6","author":"H Takigawa","year":"2016","unstructured":"Takigawa, H., Kitayama, M., Wada-Isoe, K., Kowa, H. & Nakashima, K. Prevalence of progressive supranuclear palsy in Yonago: change throughout a decade. Brain Behav. 6, e00557 (2016).","journal-title":"Brain Behav."},{"key":"1157_CR12","doi-asserted-by":"publisher","first-page":"E1479","DOI":"10.1212\/WNL.0000000000007179","volume":"92","author":"TM Marques","year":"2019","unstructured":"Marques, T. M. et al. Serum NFL discriminates Parkinson disease from atypical Parkinsonisms. Neurology 92, E1479\u2013E1486 (2019).","journal-title":"Neurology"},{"key":"1157_CR13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.parkreldis.2017.04.006","volume":"40","author":"N Malek","year":"2017","unstructured":"Malek, N. et al. Utility of the new movement disorder society clinical diagnostic criteria for Parkinson\u2019s disease applied retrospectively in a large cohort study of recent onset cases. Parkinsonism Relat. Disord. 40, 40\u201346 (2017).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1157_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.104813","volume":"139","author":"A Foubert-Samier","year":"2020","unstructured":"Foubert-Samier, A. et al. Disease progression and prognostic factors in multiple system atrophy: a prospective cohort study. Neurobiol. Dis. 139, 104813 (2020).","journal-title":"Neurobiol. Dis."},{"key":"1157_CR15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.arr.2019.01.005","volume":"50","author":"C Mueller","year":"2019","unstructured":"Mueller, C. et al. Survival time and differences between dementia with Lewy bodies and Alzheimer\u2019s disease following diagnosis: a meta-analysis of longitudinal studies. Ageing Res. Rev. 50, 72\u201380 (2019).","journal-title":"Ageing Res. Rev."},{"key":"1157_CR16","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1177\/0891988703258671","volume":"16","author":"MF Weiner","year":"2003","unstructured":"Weiner, M. F. et al. Can alzheimer\u2019s disease and dementias with Lewy bodies be distinguished clinically?. J. Geriatr. Psychiatry Neurol. 16, 245\u2013250 (2003).","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"1157_CR17","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1212\/01.WNL.0000138440.39918.0C","volume":"63","author":"N Scarmeas","year":"2004","unstructured":"Scarmeas, N. et al. Motor signs during the course of Alzheimer disease. Neurology 63, 975\u2013982 (2004).","journal-title":"Neurology"},{"key":"1157_CR18","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00401-015-1526-9","volume":"131","author":"JB Toledo","year":"2016","unstructured":"Toledo, J. B. et al. Pathological \u03b1-synuclein distribution in subjects with coincident Alzheimer\u2019s and Lewy body pathology. Acta Neuropathol. 131, 393\u2013409 (2016).","journal-title":"Acta Neuropathol."},{"key":"1157_CR19","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1002\/mds.25898","volume":"29","author":"AD Macleod","year":"2014","unstructured":"Macleod, A. D., Taylor, K. S. M. & Counsell, C. E. Mortality in Parkinson\u2019s disease: a systematic review and meta-analysis. Mov. Disord. 29, 1615\u20131622 (2014).","journal-title":"Mov. Disord."},{"key":"1157_CR20","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1212\/WNL.0000000000000641","volume":"83","author":"CH Adler","year":"2014","unstructured":"Adler, C. H. et al. Low clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic study. Neurology 83, 406\u2013412 (2014).","journal-title":"Neurology"},{"key":"1157_CR21","first-page":"1","volume":"1","author":"T Xie","year":"2015","unstructured":"Xie, T. et al. Comparison of clinical features in pathologically confirmed PSP and MSA patients followed at a tertiary center. Npj Parkinson\u2019s Dis. 1, 1\u20136 (2015).","journal-title":"Npj Parkinson\u2019s Dis."},{"key":"1157_CR22","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU H\u00f6glinger","year":"2017","unstructured":"H\u00f6glinger, G. U. et al. Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov. Disord. 32, 853\u201364. (2017).","journal-title":"Mov. Disord."},{"key":"1157_CR23","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/mds.25880","volume":"29","author":"I Stankovic","year":"2014","unstructured":"Stankovic, I. et al. Cognitive impairment in multiple system atrophy: a position statement by the Neuropsychology Task Force of the MDS Multiple System Atrophy (MODIMSA) Study Group. Mov. Disord. 29, 857\u201367. (2014).","journal-title":"Mov. Disord."},{"key":"1157_CR24","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3233\/JAD-131289","volume":"39","author":"J Horvath","year":"2014","unstructured":"Horvath, J., Burkhard, P. R., Herrmann, F. R., Bouras, C. & K\u00f6vari, E. Neuropathology of parkinsonism in patients with pure Alzheimer\u2019s disease. J. Alzheimers Dis. 39, 115\u2013120 (2014).","journal-title":"J. Alzheimers Dis."},{"key":"1157_CR25","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1093\/jnen\/nlac068","volume":"81","author":"ED Louis","year":"2022","unstructured":"Louis, E. D. et al. Characterizing Lewy pathology in 231 essential tremor brains from the essential tremor centralized brain repository. J. Neuropathol. Exp. Neurol. 81, 796\u2013806 (2022).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"1157_CR26","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s10286-020-00682-5","volume":"30","author":"C Xia","year":"2020","unstructured":"Xia, C. & Postuma, R. B. Diagnosing multiple system atrophy at the prodromal stage. Clin. Auton. Res. 30, 197\u2013205 (2020).","journal-title":"Clin. Auton. Res."},{"key":"1157_CR27","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/S0140-6736(05)66422-7","volume":"365","author":"DA Grimes","year":"2005","unstructured":"Grimes, D. A. & Schulz, K. F. Refining clinical diagnosis with likelihood ratios. Lancet 365, 1500\u20131505 (2005).","journal-title":"Lancet"},{"key":"1157_CR28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00401-020-02160-8","volume":"140","author":"M Rossi","year":"2020","unstructured":"Rossi, M. et al. Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies. Acta Neuropathol. 140, 49\u201362 (2020).","journal-title":"Acta Neuropathol."},{"key":"1157_CR29","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1002\/mds.27802","volume":"34","author":"S Heinzel","year":"2019","unstructured":"Heinzel, S. et al. Update of the MDS research criteria for prodromal Parkinson\u2019s disease. Mov. Disord. 34, 1464\u20131470 (2019).","journal-title":"Mov. Disord."},{"key":"1157_CR30","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","volume":"80","author":"MJ Armstrong","year":"2013","unstructured":"Armstrong, M. J. et al. Criteria for the diagnosis of corticobasal degeneration. Neurology 80, 496\u2013503 (2013).","journal-title":"Neurology"},{"key":"1157_CR31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1126\/science.130.3366.9","volume":"130","author":"RS Ledley","year":"1959","unstructured":"Ledley, R. S. & Lusted, L. B. Reasoning foundations of medical diagnosis; symbolic logic, probability, and value theory aid our understanding of how physicians reason. Science 130, 9\u201321 (1959).","journal-title":"Science"},{"key":"1157_CR32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/jes.2008.72","volume":"20","author":"SP Caudill","year":"2010","unstructured":"Caudill, S. P. Characterizing populations of individuals using pooled samples. J. Expo. Sci. Environ. Epidemiol. 20, 29\u201337 (2010).","journal-title":"J. Expo. Sci. Environ. Epidemiol."},{"key":"1157_CR33","unstructured":"Shreffler, J. & Huecker, M. R. Diagnostic testing accuracy: sensitivity, specificity, predictive values and likelihood ratios. [Updated 2022 Mar 9]. In StatPearls [Internet] (StatPearls Publishing, Treasure Island, FL, 2022)."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01157-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01157-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01157-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:03:57Z","timestamp":1762819437000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01157-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1157"],"URL":"https:\/\/doi.org\/10.1038\/s41531-025-01157-y","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"16 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"314"}}